Levicept Ltd

Just over a decade after Simon Westbrook bought a promising non-addictive he had developed from former employer Pfizer Inc. , the company he formed – Levicept Ltd – has posted promising mid-stage da

“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning

Since biotech valuations on public markets peaked in September 2021, the sector has had to contend with reduced financing availability and harsher conditions for deal-making. In December 2023, Scrip

Start-Up Execs Aileron Therapeutics Inc. Manuel C. Aivado, MD, PhD To: CMO (October) From: VP, Clinical Dev. &Pharmacovigilance, Taiho Oncology Phone: 617-995-0900 Donna M. Jarlenski To: VP, C